Long-term effect of tocilizumab in patients with giant cell arteritis: open-label extension phase of the Giant Cell Arteritis Actemra (GiACTA) trial
- Resource Type
- Article
- Source
- In
The Lancet Rheumatology May 2021 3(5):e328-e336 - Subject
Primary Research Articles - Language
- ISSN
- 2665-9913